跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
CBD-50
首页
药物
CBD-50
CBD-50
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
ORAL CANNABINOID FORMULATIONS
申请人: GW RES LTD
优先权: 2019
CN
EP
US
WO
4 件公开
Method and composition for treating cachexia and eating disorders
申请人: INDIA GLOBALIZATION CAPITAL INC
优先权: 2015
US
WO
2 件公开
USE OF CANNABIDIOL IN THE TREATMENT OF SEIZURES ASSOCIATED WITH AURICULOTEMPORAL SYNDROME
申请人: GW RES LTD
优先权: 2020
WO
USE OF CANNABIDIOL IN THE TREATMENT OF SEIZURES ASSOCIATED WITH MULTIFOCAL EPILEPSY SYNDROME
申请人: GW RES LTD
优先权: 2020
WO
CANNABIDIOL AND CURCUMIN FOR TREATING INFLAMMATORY DISEASES
申请人: BOL PHARMA LTD
优先权: 2018
WO
USE OF CANNABIDIOL IN THE TREATMENT OF SEIZURES ASSOCIATED WITH SHAKEN BABY SYNDROME
申请人: GW RES LTD
优先权: 2020
WO
USE OF CANNABIDIOL IN THE TREATMENT OF SEIZURES ASSOCIATED WITH HERPES SIMPLEX VIRUS
申请人: GW RES LTD
优先权: 2020
EP
US
WO
3 件公开
USE OF CANNABIDIOL IN THE TREATMENT OF SEIZURES ASSOCIATED WITH ENCEPHALITIS
申请人: GW RES LTD
优先权: 2020
WO
药物
反馈